NEW YORK (Reuters Health), Nov 13 -- Radiolabeling antibodies to HIV proteins may provide a successful strategy against the infection, investigators in Germany and the U.S. report in the November issue of PLoS Medicine.
An antibody to HIV-1 envelope glycoprotein 41 tagged with the radioisotope rhenium-188 kills cultured white blood cells either chronically or acutely infected with HIV-1, report Ekaterina Dadachova, of the Albert Einstein College of Medicine in Bronx, New York, and her colleagues. The same agent selectively kills HIV-1-infected cells in two mouse models of human infection, without causing acute hematologic toxicity.
"We envision that the availability of radioimmunotherapy could provide a novel treatment option that may hasten the day when curative regimens are available for the eradication of HIV-1 infections," the team writes.
A similar strategy is already used to treat some cancers, note the researchers. Her group also has demonstrated that radioimmunotherapy can treat fungal and bacterial infections by targeting the microbes themselves.
Now they suggest that this tactic would be even more effective in treating HIV-1 infection, because "the majority of long-lived infected cellular targets are lymphocytes, which are among the most radiosensitive cells in the body." Moreover, this type of treatment may be particularly beneficial for eliminating persistent reservoirs of infected cells.
Their most successful candidate was an antibody to the HIV-1 envelope transmembrane protein gp41, labeled with the radioisotope rhenium-188. In vitro treatment led to the killing of chronically infected human T cells and acutely infected human peripheral blood mononuclear cells.
To test the labeled antibody in vivo, the research team used severe combined immunodeficiency (SCID) mice harboring HIV-1 infected mononuclear cells in their spleens. One hour after infection, the researchers injected their concoction.
By increasing the dose, the authors were able to almost completely eliminate the HIV-1-infected cells. The radiolabeled antibody was also effective in a mouse model of an infected human thymus.
Only at the highest dose was there a nonsignificant decrease in platelet count, which recovered by day 15. The researchers attribute this lack of hematologic toxicity to the specific targeting of HIV-1-infected cells. Unlike tumor cells, they write, "cells expressing microbial antigens are antigenically very different from host tissues and thus provide the potential for exquisite specificity and low-cross-reactivity."
Dr. Dadachova and her associates suggest that radioimmunotherapy would be effective immediately after HIV exposure or for infections caused by multi-drug resistant HIV-1. They add that combination therapy with HAART, or "a cocktail of monoclonal antibodies to various epitopes on the HIV-1 envelope may be desirable."
In a press release from the Albert Einstein College of Medicine, senior author Dr. Arturo Casadevall remarks that "this work introduces a new approach for treating many viral infections, from hepatitis C to Ebola."
Last Updated: 2006-11-13 10:30:08 -0400 (Reuters Health)
PLoS Medicine 2006;3:e427.
Related Reading
Lung cancer particularly aggressive in patients with HIV, October 4, 2006
Copyright © 2006 Reuters Limited. All rights reserved. Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Reuters and the Reuters sphere logo are registered trademarks and trademarks of the Reuters group of companies around the world.
![Examples of ultrasound findings and techniques. (A) Images in a 39-year-old male patient with a mass in the left thigh. The mass is heterogeneous on the B-mode US image (compared with the patient in D) and showed increased microvascularity (superb microvascular imaging [SMI]) and shear-wave elastography (SWE) values. Undifferentiated pleomorphic sarcoma was diagnosed at biopsy (with pleomorphic rhabdomyosarcoma in surgical specimen). (B) Images in an 18-year-old male patient with a mass in the left leg. The mass is hypoechoic on the B-mode image, with no other findings suggestive of malignancy. The lesion is in contact with the cortex of the tibia, which is slightly irregular. CT revealed a doubtful anteromedial tibial erosion. The microvascular study demonstrated high vascularization, suggestive of malignancy. Periosteal Ewing sarcoma was diagnosed with both histologic and immunohistochemical confirmation. (C) Images in a 69-year-old female patient with a lump growing on the outside of the left leg. Multiple SWE examinations were performed (please note the high values obtained in the measurements, whereas the color map highlights the stiffness relative to adjacent tissues). SMI showed areas of increased vascularization to target for sampling. Undifferentiated spindle cell sarcoma was diagnosed at biopsy, with residual leiomyosarcoma in the surgical specimen after neoadjuvant therapy. (D) Images in a 56-year-old female patient with a mass in the right thigh. The mass is heterogeneous at both B-mode ultrasound (similar to patient A) and MRI (coronal T2-weighted spectral attenuated inversion recovery [SPAIR]; T1-weighted pre-contrast and postcontrast imaging), which even shows uptake after the administration of paramagnetic contrast material, which is traditionally suggestive of malignancy. Low values at SMI and elastography are suggestive of benignity. Spindle cell lipoma was diagnosed at biopsy, with atypical spindle cell lipomatous tumor in the surgical specimen.](https://img.auntminnieeurope.com/mindful/smg/workspaces/default/uploads/2026/08/images-radiol250278fig2.APCFLSvX6p.jpg?auto=format%2Ccompress&fit=crop&h=100&q=70&w=100)
![Examples of ultrasound findings and techniques. (A) Images in a 39-year-old male patient with a mass in the left thigh. The mass is heterogeneous on the B-mode US image (compared with the patient in D) and showed increased microvascularity (superb microvascular imaging [SMI]) and shear-wave elastography (SWE) values. Undifferentiated pleomorphic sarcoma was diagnosed at biopsy (with pleomorphic rhabdomyosarcoma in surgical specimen). (B) Images in an 18-year-old male patient with a mass in the left leg. The mass is hypoechoic on the B-mode image, with no other findings suggestive of malignancy. The lesion is in contact with the cortex of the tibia, which is slightly irregular. CT revealed a doubtful anteromedial tibial erosion. The microvascular study demonstrated high vascularization, suggestive of malignancy. Periosteal Ewing sarcoma was diagnosed with both histologic and immunohistochemical confirmation. (C) Images in a 69-year-old female patient with a lump growing on the outside of the left leg. Multiple SWE examinations were performed (please note the high values obtained in the measurements, whereas the color map highlights the stiffness relative to adjacent tissues). SMI showed areas of increased vascularization to target for sampling. Undifferentiated spindle cell sarcoma was diagnosed at biopsy, with residual leiomyosarcoma in the surgical specimen after neoadjuvant therapy. (D) Images in a 56-year-old female patient with a mass in the right thigh. The mass is heterogeneous at both B-mode ultrasound (similar to patient A) and MRI (coronal T2-weighted spectral attenuated inversion recovery [SPAIR]; T1-weighted pre-contrast and postcontrast imaging), which even shows uptake after the administration of paramagnetic contrast material, which is traditionally suggestive of malignancy. Low values at SMI and elastography are suggestive of benignity. Spindle cell lipoma was diagnosed at biopsy, with atypical spindle cell lipomatous tumor in the surgical specimen.](https://img.auntminnieeurope.com/mindful/smg/workspaces/default/uploads/2026/08/images-radiol250278fig2.APCFLSvX6p.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
